During wound repair, branching morphogenesis and carcinoma dissemination, cellular rearrangements are fostered by a solidto-liquid transition, known as unjamming. The biomolecular machinery behind unjamming and its pathophysiological relevance remain, however, unclear. Here, we study unjamming in a variety of normal and tumorigenic epithelial two-dimensional (2D) and 3D collectives. Biologically, the increased level of the small GTPase RAB5A sparks unjamming by promoting non-clathrin-dependent internalization of epidermal growth factor receptor that leads to hyperactivation of the kinase ERK1/2 and phosphorylation of the actin nucleator WAVE2. This cascade triggers collective motility effects with striking biophysical consequences. Specifically, unjamming in tumour spheroids is accompanied by persistent and coordinated rotations that progressively remodel the extracellular matrix, while simultaneously fluidizing cells at the periphery. This concurrent action results in collective invasion, supporting the concept that the endo-ERK1/2 pathway is a physicochemical switch to initiate collective invasion and dissemination of otherwise jammed carcinoma.
C ollective motility is ruled by both biochemical and physical interactions that cells establish among each other and with their environment 1, 2 . During tissue growth, cells are free to move, as in a fluid, but their motion becomes constrained as density increases. At a critical density-depending on a variety of biophysical parameters, such as intercellular adhesion, cortical tension, single-cell motility and cell shape variance-motility ceases and collectives rigidify, undergoing a jamming transition [3] [4] [5] [6] [7] . This transition ensures proper development of barrier properties in epithelial tissues, but also acts as a tumour-suppressive mechanism 3, 8 . The reverse solid-to-liquid (unjamming) transition might, instead, represent a complementary gateway to epithelial cell migration, enabling mature tissues to flow 3, 8, 9 . However, how cells control the jamming and unjamming transitions is unclear.
Consistently with the emerging role of membrane trafficking in regulating cell migration plasticity and the mechanics of cell-cell interactions 10, 11 , we recently found that RAB5A, a master regulator of early endosomes necessary to promote a mesenchymal program of individual cancer invasion 12, 13 , impacts on the mechanics and dynamics of multicellular, normal and tumorigenic cell assemblies 14 . RAB5A overexpression reawakens the motility of otherwise kinetically arrested epithelial monolayers, promoting millimetre-scale, multicellular, ballistic cell locomotion and a flocking-fluid motility pattern through large-scale coordinated migration and local cell rearrangements [14] [15] [16] . Concurrently, monolayer stiffness, cellcell surface contact and junctional tension increase, as well as the turnover of junctional E-cadherin and the extension of RAC1-driven protrusions 14 . Molecularly, impairing endocytosis, macropinocytosis or increasing fluid efflux abrogated RAB5A-induced collective motility, suggesting that perturbations of trafficking processes are necessary for the unjamming transition. However, the molecular nature of these endocytic-sensitive pathways is yet unidentified. Even less clear is whether this transition occurs in relevant physiological, 3D settings and whether it can promote collective dissemination of dense, jammed carcinoma.
Here, we identify a necessary axis of the flocking transition in a variety of jammed collectives. RAB5A overexpression enhances the internalization of the epidermal growth factor receptor (EGFR) through non-clathrin-dependent routes into endosomes, which causes hyperactivation of the extracellular signal-regulated protein kinases ERK1/2 and the phosphorylation of the branched actin nucleator, WAVE2 17 . This endocytic-ERK1/2 axis is sufficient to overcome the kinetic and proliferation arrest of mammary cysts in three dimensions. It also stimulates coherent rotation of breast ductal carcinoma in situ (DCIS) spheroid models, which causes both a radial gradient of cell fluidification and a stress-induced remodelling of the surrounding extracellular matrix (ECM). These effects combine to promote collective invasion of DCIS spheroids and ex vivo slices of orthotopically implanted DCIS, pointing at the identified RAB5A-mediated, epidermal growth factor (EGF)-dependent activation of endosomal ERK1/2 as a key molecular route to the unjamming-via-flocking transition. Pathologically, the identified pathway appears relevant for breast carcinoma, RAB5A expression being upregulated in invasive foci of human DCIS and correlating with worse disease-free survival.
Results
EGFR trafficking controls flocking-liquid motility. RAB5A expression promotes a flocking transition in jammed, solid epithelial monolayers 14 through ill-defined molecular mechanisms and signalling axes. Particle image velocimetry (PIV) revealed that RAB5A expression enhanced cell motility, quantified by the root mean square velocity V RMS (see Methods). It further promoted millimetre-scale coordination, measured by the velocity correlation length L corr , and directed collective motion over a distance larger than ~700 μm, quantified by the persistence length L pers , confirming previous results 14 . Removal of EGF, required for proliferation and single-cell motility of the MCF10A line 18 , or addition of AG1478, an inhibitor of the EGFR kinase 19 , abrogated RAB5A-induced flocking (Supplementary Videos 1, 2 and 4), with V RMS , L corr and L pers reverting to values typical of control cells (Fig. 1a ). These treatments further impacted on the uniformity of the migration pattern ( Fig. 1b ). We confirmed these results using EGFP-H2B-expressing cells to visualize nuclear cell displacements (Supplementary Video 3). Finally, similar EGF-dependency of collective motion was also observed in serum-starved, jammed keratinocyte monolayers, HaCat 20 , and in oncogenically transformed MCF10A variants, MCF10.DCIS.com ( Supplementary Fig. 8a and Supplementary Video 20) .
Next, we tested whether alterations of endosomal biogenesis caused by RAB5A 21 perturbed EGFR cellular distribution, trafficking or signalling. Firstly, we showed that the total protein but not the messenger RNA (mRNA) levels of EGFR were significantly reduced following induction of RAB5A expression ( Fig. 1c,d) . The fraction of phosphorylated EGFR was, instead, unexpectedly increased ( Fig. 1c) . Secondly, RAB5A-expressing cells display a marked reduction of cell surface EGFR accompanied by increased intracellular EGFR, which accumulates in EEA1-positive, early endosomes ( Fig. 1e-g) . Measurements of the absolute number of surface EGFR using 125 I-EGF binding corroborated the immunofluorescence data ( Fig. 1h ). Finally, by immunofluorescence analysis ( Supplementary Fig. 1a-c and Supplementary Table 1 ) and by determining the number of EGFR molecules on the plasma membrane ( Supplementary Fig. 1d ), we verified that the removal of the ligand and inhibition of EGFR kinase activity restore surface and intracellular distribution of EGFR to levels of control cells.
Intracellular accumulation of EGFR might originate from increased internalization or reduced recycling. In the former case, it is known that for a low EGF dose (1 ng ml -1 ), EGFRs are primarily internalized by clathrin-mediated endocytosis 22 and recycled back to the plasma membrane 23 . For large physiological EGF concentrations (20-100 ng ml -1 ), non-clathrin endocytosis 24 is activated in parallel to clathrin-mediated endocytosis 23, 25 . RAB5A expression significantly increased the apparent endocytic rate constant (K e ) at high (30 ng ml -1 ) but not at low (1 ng ml -1 ) 125 I-EGF concentrations ( Fig. 2a ). We also measured the recycling rates of EGFR, which were not significantly altered by elevation of RAB5A (Fig. 2b) , and the total levels of EGFR, which slowly, but progressively, decreased over time consistent with the augmented non-clathrin internalization that target EGFR to degradation ( Supplementary Fig. 1e ). To reinforce this finding, we measured EGFR internalization at high doses of ligands after silencing critical determinants of clathrinand non-clathrin-endocytosis. We found that silencing dynamin-2 robustly reduced EGFR internalization by more than 80% in both control and RAB5A cells, consistent with the expected requirement of this protein for EGFR entry (Fig. 2c,d and Supplementary Table 2 ). The silencing of clathrin inhibited EGFR internalization to an extent similar to that achieved by dynamin-2 small interfering RNA (siRNA) in control cells, but was significantly less effective in RAB5A-expressing cells (Fig. 2c,d and Supplementary Table  2 ). Finally, the RAB5A-dependent increased rate of endocytosis was reduced to control levels after silencing of the endoplasmic reticulum (ER)-resident protein reticulon 3 (RTN3), essential for non-clathrin endocytosis 25 (Fig. 2c ), or by impairing macropinocytosis using 5-(N-ethyl-N-isopropyl) amiloride (EIPA) 26 (Fig. 2e ). Collectively, these findings indicate that RAB5A promotes EGFR non-clathrin endocytosis, leading to the accumulation of EGFR into early endosomes and, possibly, to the reawakening of collective motion. Indeed, silencing of dynamin-2 ( Supplementary Fig.  2a ,b and Supplementary Video 5), or RTN3, but not of its highly related ER resident protein RTN4 ( Supplementary Fig. 2c,d and Supplementary Video 6), impaired RAB5A-induced flocking.
RAB5A activates ERK1/2 to regulate cell protrusion dynamics.
EGFR signalling has been proposed to be initiated at the plasma membrane but to continue in endosomes [27] [28] [29] , which act as signalling quanta-like platforms where phosphorylated EGFR can be packaged at constant mean amounts 30 . As a consequence, altering the size and number of endosomes directly affected EGFR signalling. Hence, we monitored EGFR downstream pathways following RAB5A expression.
We found no impact on phosphorylation levels of the two kinases AKT and p38, variably involved in motility, whereas phosphorylated ERK1/2 was increased ( Fig. 3a ) and long-lived in RAB5A-expressing cells ( Supplementary Fig. 3a and Supplementary  Table 3 ). We corroborated this finding by immunofluorescence after mixing control and EGFP-H2B-RAB5A-expressing cells ( Supplementary Fig. 3b ). Notably, ERK1/2 activation was detectable only in RAB5A-, but not in RAB5B-or RAB5C-expressing cells ( Supplementary Fig. 3c,d) . Only RAB5A increased significantly both the number and size distribution of EEA1-positive endosomes 
when the local velocity is parallel (antiparallel) to the mean direction of migration. Scale bar, 100 μm. c, Immunoblot of the indicated proteins and quantification of total EGFR and phosphorylated/total EGFR value. Data are expressed relative to control after normalizing to vinculin (mean ± s.d., n = 5 independent experiments). M w , molecular weight. d, Relative EGFR mRNA levels normalized to GAPDH (mean ± s.d., n = 5 independent experiments). e, Control and RAB5A-MCF10A cells were either permeabilized with 0.1% Triton X100 or not permeabilized before staining. Scale bar, 20 μm. f, Data are mean ± s.d. of total cell surface or internalized EGFR relative to control normalized to cell number (n = 100 cells in three independent experiments). g, Images of control and RAB5A-MCF10A monolayers stained with the indicated antibodies. Data are the mean ± s.d. of EEA1-and EGFR-positive vesicles/cells (n > 150 out of three independent experiments). Scale bar, 20 μm. h, Number of EGFRs per cell measured by 125 I-EGF saturation binding after subtracting unspecific background. Data are the mean ± s.d. of triplicate measurements. **p < 0.01, ***p < 0.001, each-pair Student's t-test. n.s., not significant.
( Supplementary Fig. 3e -h and Supplementary Table 4 ), and significantly reduced surface EGFR levels, while augmenting the number of EGFR-positive structures ( Supplementary Fig. 4a-e ). RAB5B, instead, had marginal effects on endosome size and number, whereas RAB5C decreased significantly endosome number but robustly increased the size of EEA1-and EGFR-positive endosomes, which were concentrated perinuclearly (Supplementary Figs. 3e-h and 4a-e). RAB5B and RAB5C were also very inefficient in reawakening collective motion in jammed monolayers ( Supplementary Fig.  4f and Supplementary Video 7). Additionally, pharmacological inhibition of ERK1/2 using PD0325901 that targets the upstream MEK kinase 31 , or SCH772984 that directly inhibits ERK1/2 activity, abrogated RAB5A-induced flocking ( Fig. 3b and Supplementary Video 8). Treatment with AG1478 or dynasore, a small molecule impairing dynamin-2 activity 32 , inhibited RAB5A-mediated elevation of ERK1/2 ( Fig. 3c ) and blocked the reawakening of collective , suggesting that RAB5A elevation might enhance endosomal ERK1/2 signalling. This conjecture was tested by generating a Förster resonance energy transfer (FRET) EKAREV-ERK1/2 sensor 33 , targeted to the endosomes by appending the FYVE domain of SARA protein to its C-terminus 34 ( Supplementary Fig. 4g ,h). Removal of EGF or treatment with PD0325901 significantly impaired FRET efficiency, validating the biological relevance of the sensor ( Supplementary Fig. 4i ). More importantly, RAB5A-expressing cells displayed increased endosomal ERK1/2 FRET efficiency as compared with control monolayers ( Supplementary Fig. 4j ). We further showed that global elevation of ERK1/2 phosphorylation induced by the expression of Cells with cryptic lamellipodia (%) a constitutively activated MEK-DD did not reawaken motility in jammed monolayers ( Supplementary Fig. 5a ,b and Supplementary Video 10). Notably, MEK-DD had no impact on junctional straightness or morphology ( Supplementary Fig. 5c,d ). Collectively, our findings indicate that ERK1/2 activation is necessary, albeit not sufficient, to promote unjamming. RAB5A-expressing, unjammed monolayers move in a directed fashion by extending oriented cryptic lamellipodia 14, 35 (Fig. 3d ). Cryptic lamellipodia depend on RAC1, which activates branched actin polymerization of the pentameric WAVE2 complex 36 . The key component of this complex, WAVE2 is phosphorylated by ERK1/2 on multiple serine residues, among which S343 and S351, to be activated and to control protrusion dynamics 37 . Consistently, we found that RAB5A expression increased the phosphorylation of WAVE2, but marginally of ABI1, another key component of the WAVE complex 36 , in an ERK1/2-, EGFR-and dynamin-2-dependent manner ( Supplementary Fig. 6a -c). Additionally, by monitoring the dynamics of cells mosaically expressing EGFP-LifeAct, we found that pharmacological inhibition of ERK1/2 impaired the formation and dynamics of cryptic lamellipodia (Fig. 3d ,e and Supplementary Video 11). Similar results were obtained by silencing of NAP1, a critical member of the complex. This treatment destabilized both WAVE2 and ABI1 proteins ( Fig. 3f ), as previously shown 38, 39 , impaired cryptic lamellipodia dynamics ( Fig. 3g and Supplementary Video 12), flocking ( Fig. 3h and Supplementary Video 13) and wound closure ( Supplementary Fig. 6d-f and Supplementary Video 14) . Silencing of only WAVE2 in MCF10A cells, which also express WAVE1 and WAVE3 mRNA ( Supplementary Fig. 6g ), was, as expected, less effective ( Supplementary Fig. 6d ,e and Supplementary Video 14).
Unjamming terminally differentiated mammary acini. To explore the biological consequences of the RAB5A-induced endo-ERK1/2 axis, we exploited the ability of MCF10A cells to generate differentiated, kinetically and proliferation-arrested hollow cysts grown over Matrigel plugs 18 ( Supplementary Fig. 7a ). We employed mCherry-H2B-expressing control and RAB5A cells to monitor the kinematics of differentiated cysts (Fig. 4a ). Cells in control differentiated acini were kinetically arrested, whereas expression of RAB5A reawakened motility by triggering rotational motion (Fig. 4b,c and Supplementary Video 15). With custom PIV, we quantified the tangential rotational velocity field and extracted relevant kinematic parameters, such as V RMS and the rotational order parameter ψ, which can vary between 0 (absence of coordinated motion) and 1 (for a rigidly rotating sphere) (see Methods). Control acini displayed barely detectable V RMS , with ψ below 0.2 ( Fig. 4c and Supplementary Videos 15 and 16), whereas following RAB5A expression ψ reached a value close to 1 in correspondence to the maximum of V RMS ( Fig. 4c and Supplementary Videos 15 and 16).
Impaired EGFR activity, ERK1/2 phosphorylation and dynamin endocytosis reduced V RMS and ψ to control levels ( Fig. 4d and Supplementary Video 17). Additionally, RAB5A cysts displayed elevated phospho-ERK1/2 ( Supplementary Fig. 7b ) and straight and compact junctions ( Supplementary Fig. 7c ), indicating that RAB5A impacts on similar biochemical and microscopic determinants as in 2D monolayers 14 .
We also noticed that inducing RAB5A expression in the initial phase of cystogenesis reduced the number of acini, but the ones remaining were significantly larger ( Fig. 4e,f) , and did not undergo proliferation arrest, like control cysts do, as revealed by Ki67 staining, or apoptosis ( Supplementary Fig. 7d ). Importantly, proliferation was not a prerequisite for motility, since treatment with Mitomycin C had no effects on rotations (Supplementary Video 18). We investigated this phenotype further by inducing RAB5A expression at the end of morphogenesis, when fully differentiated acini have ceased proliferation and motility 18 . RAB5A expression reawakened not only cell motility (Supplementary Video 19), but also proliferation in an ERK1/2-dependent manner (Fig. 4g,h) .
The ERK1/2-dependent reawakening of collective motion and proliferation of terminally differentiated acini has been associated with the initiation of a more complex program of branched morphogenesis that begins with the formation of multicellular buds 40 . This process requires in addition to specific growth factors, also cell interaction with the microenvironment and ECM components 41, 42 . Collagen type-I, for example, has been used to increase chemomechanical signalling and facilitate duct morphogenesis 43 . Henceforth, we grew MCF10A cells over mixed Matrigel-collagen gels 42 . Under these conditions, RAB5A expression caused cysts to lose their spherical roundness, and promoted the formation of buds ( Fig. 4i,j) .
Endocytic unjamming promotes carcinoma collective invasion.
To determine whether RAB5A unjamming can be exploited by breast cancer lines to enhance collective motility and invasiveness, we employed MCF10.DCIS.com cells, which are isogenic to MCF10A cells, express oncogenic T24-H-RAS and are used as models for the progression of DCIS to invasive carcinoma 44 . During the DCIS phase, cells grow under intraductal confinement where cell packing and density exert mechanical stress and supress tumour motility and progression. Consistently, MCF10.DCIS.com cells plated as confluent monolayers are kinetically arrested. RAB5A expression promoted the reawakening of collective motion 14 ( Supplementary  Fig. 8a and Supplementary Video 20) and accelerated wound closure of monolayers, which instead of arresting after the opposing fronts collided kept on flowing, reminiscent of 'a wound that never heals' 45 ( Fig. 5a -c and Supplementary Video 21). Biochemically, RAB5A expression decreased total EGFR levels, but increased ERK1/2 without affecting AKT or p38 phosphorylation ( Supplementary Fig.  8b ). Next, we monitored the kinematics of mCherry-H2B control and RAB5A-expressing MCF10.DCIS.com spheroids embedded into native collagen type-I by developing 3D differential variance analysis (see Methods). Whereas control cells displayed a slow, uncorrelated, disordered motion ( Fig. 5d,e, Supplementary Fig.  8c and Supplementary Video 22) , RAB5A-MCF10.DCIS.com cells acquired collective rotational motility, characterized by a large angular velocity Ω (of the order of ~12 rad h -1 ) and a strong orienta-tional persistence of the instantaneous axis of rotation, captured by the decay time of the orientational correlation function ( Fig. 5e and Supplementary Fig. 8c ). We also observed a speed-up of the local cell rearrangement dynamics, estimated by calculating the overlap parameter Q(Δt), which quantifies (see Methods) the fraction of nuclei that have been displaced from their original position during a time interval of duration (Δt) when observed in a reference frame co-moving with the whole spheroid ( Fig. 5e and Supplementary Fig.  8c ). The decay of Q(Δt) does not depend on the rigid motion of the spheroid as a whole, but captures, instead, the 'fluid-like' relative motion of cells. By repeating the same analysis in a space-resolved fashion (see Methods), we discovered that, for RAB5A-MCF10.DCIS.com spheroids, the decorrelation rate associated with the decay of the local overlap parameter displayed a systematic radial dependence, being much larger at the periphery of the spheroid (Fig. 5f,g) . The presence of a 'melted' layer of cells on the surface of the rotating spheroid was confirmed by an optical-flow analysis (see Methods) of the velocity fluctuations (Supplementary Video 23) that, after removal of the global rotation, exhibited a marked increase close to the boundaries (Fig. 5f,g) .
Endocytic-mediated liquid-like collective rotation in RAB5A-MCF10.DCIS.com spheroids was dependent on EGFR activity, ERK1/2 phosphorylation and dynamin-2 and abrogated by inhibiting ARP2/3-mediated actin polymerization ( Supplementary Fig. 8c and Supplementary Video 24). Furthermore, electron microscopy morphological analysis of monolayers, spheroids and orthotopically injected tumours revealed that RAB5A expression induces junctional straightening and increases cell-cell contact area (Fig. 5h ). Thus, similar cellular/biochemical processes driving 2D locomotion and acini morphogenesis control the dynamics of oncogenic epithelial ensembles.
Next, we explored the consequence of endocytic-mediated unjamming by monitoring oncogenic spheroids co-expressing EGFP-LifeAct and mCherry-H2B over longer timescales. Invariably, RAB5A promoted collective angular motion and the formation of invasive, multicellular buds and strands, suggesting that unjamming and collective invasion might be temporally coordinated and possibly coupled (Fig. 6a,b and Supplementary Video 25).
Collective invasion into native collagen type-I, which, at the concentration used, forms a dense fibrillar network ( Supplementary  Fig. 8d ), can only occur following its remodelling. To verify this, we exploited fluorescent functionalized-beads that bind to the collagen fibres, impeding relative motion between beads and the ECM used to embed the spheroids ( Fig. 6c and Supplementary Video 26). We developed stress fluctuation microscopy (see Methods) to infer, from the instantaneous velocity maps of the tracers (Supplementary Video 27), an estimate of the root mean square (RMS) values of the fluctuating strains induced by the cellular motion onto the ECM. Reconstructed normal RMS stresses are obtained (Fig. 6d,e and Supplementary Video 27) via the constitutive equations of the material, whose Young's modulus E = 135 ± 57 Pa was measured using atomic force microscopy ( Supplementary Fig. 8d ). The RMS stresses imposed on the matrix by RAB5A spheroids were about two times larger than controls (Fig. 6e) . The corresponding RMS normal strain at the boundary of RAB5A-expressing cells was of the order of about 10%, well above the critical value (strain ~5-6.5%) at which native collagen gels start exhibiting a nonlinear mechanical response and strain-induced remodelling [46] [47] [48] . Consistently, RAB5Aexpressing rotating spheroids extensively remodelled fibrillary collagen, detected by second-harmonic generation signals of twophoton illumination, generating gaps and channels ( Supplementary  Fig. 8e ). EGFR, ERK1/2, dynasore and ARP2/3 inhibitor of collective angular motion also prevented collagen remodelling and invasion (Fig. 6f ).
Next, we extended this finding using ex vivo organotypic tumour slices from mCherry-H2B-and EGFP-LifeAct-expressing DCIS orthotopically injected into immunocompromised mice. Tumour masses were mechanically excised and grown as organotypic tissue slices at the air/liquid interface (see Methods and ref. 49 ). Whereas control tumours were immobile, jammed and compacted, RAB5A-expressing malignant cells became highly motile and appeared to stream like a flowing liquid (Supplementary Video 28), also captured by PIV (Fig. 6g,h and Supplementary Video 29). Thus, endocytic unjamming of kinetically arrested DCIS tumours is sufficient to instigate motility and promote collective invasion.
The pathophysiological relevance of our findings is underscored by the observations that RAB5A is deregulated in breast cancer 13, 50 , and specifically during the invasive progression of human ductal breast carcinomas. Indeed, RAB5A expression was low in malignant cells of densely packed and jammed DCIS foci. The percentage of strongly expressing RAB5A cells increased at foci of DCIS associated with invasive components or in overt infiltrating carcinomas (IDC) ( Supplementary Fig. 9a ). Additionally, increased RAB5A expression was detected in aggressive breast cancer cell lines ( Supplementary  Fig. 9b ), and correlated with worse relapse-free probability in various breast cancer subtypes ( Supplementary Fig. 9c ).
Conclusions
We identify a molecular route that reinstates multicellular rearrangements in otherwise immobile mature epithelia and densely packed carcinoma. Biochemically we showed that elevated RAB5A enhances non-clathrin endocytosis of EGFR and promotes its accumulation into endosomal vesicles, which become signalling platforms for the prolonged and elevated activation of ERK1/2. This, in turn, is sufficient to promote the hyperphosphorylation of WAVE2 that, by controlling actin polymerization, contributes to the extension of oriented, cryptic lamellipodia 35 . Physically, the latter protrusions exert increased traction forces 14, 51 , and enhance cell orientation, promoting flocking in epithelia monolayers and longrange coordinated rotation in 3D cysts and spheroids.
Remarkably, RAB5A-expressing spheroids display a radial gradient of fluidity whereby cells at the periphery in contact with the ECM exhibit faster rearrangement dynamics and increased tissue fluidization. These kinematic changes are linked to increased strains and/or stresses exerted on the surrounding ECM beyond the threshold for remodelling fibrillar collagen 46 , thereby facilitating the generation of tracks and channels into which fluidized cells advance collectively. These mechanical changes are remarkably reminiscent of the graded unjamming (solid-to-fluid) transition observed along the body axis of developing zebrafish embryo and shown to drive body axis elongation 52 graded fluidization specifically, might be a general physical mechanism of diverse multicellular collectives. This mechanism might emerge as an adaptive 'smart material' strategy of cell collectives in response to variations in the chemical/mechanical composition of the ECM and might further impact on the structural composition of the surrounding stroma. Within this context, the transition from DCIS, which grow under intraductal confinement where extreme cell packing and density exert mechanical stress and supress motility, to invasive carcinoma, which disperse locally also through collective invasion 53 , represents a case in point.
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Methods
Plasmids, antibodies and reagents. Doxycycline-inducible lentiviral vectors, pSLIK-neomycin (neo) carrying RAB5A or RAB5C sequences and pSLIKhygromycin (hygro) carrying the RAB5B sequence were obtained from Gateway Technology (Invitrogen), and prepared following the manufacturer's protocol. The plasmids pBABE-puromycin (puro)-mCHERRY-H2B and pBABE-puro-EGFP-H2B were provided by the IFOM Imaging Facility. The lentiviral expression construct pRRL-LifeAct-EGFP-puromycin (puro) was a gift from O. Pertz (University of Basel, Basel, Switzerland). The pBABE-Puro-MEK-S218D/S222D (MEK-DD) vector was purchased from Addgene. The FRET EKAREV-ERK1/2 sensor 53 was generated by cloning the synthetized FYVE domain of SARA into the BamHI/EcoRI cleaved EKAREV-FRET vector to generate the pPBbsr2-3560NES-EKAREV-FRET vector.
Mouse monoclonal antibodies raised against α−tubulin (catalogue (cat.) no. T5168) or vinculin (cat. no. V9131) were from Sigma-Aldrich (dilution 1:400). Rabbit polyclonal anti-RAB5A (S-19, cat. no. sc-309) and goat polyclonal anti-EEA-1 (N-19, cat. no. sc-6415) antibodies were from Santa Cruz Biotechnology (dilution 1:400). Monoclonal rabbit anti-human RAB5A (cat. no. ab109534, dilution 1:100, Abcam EPR5438) was used of immunohistochemistry (IHC). Rabbit polyclonal anti-Giantin (cat. no. PRB-114C) antibody was from Covance. Mouse monoclonal anti-human Ki-67 antigen (MIB-1, cat. no. M7240) antibody was from Dako (1:1,000) . Mouse monoclonal anti-AP50 (AP2mu) (31/AP50, cat. no. 611350) was from BD Bioscience. Mouse monoclonal anti-E-cadherin (cat. no. 610181) antibody was from Transduction Lab (dilution 1:1,000). Rabbit polyclonal anti-phospho-EGFR (Tyr1086, cat. no. 2220), rabbit monoclonal anti-phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr204, cat. no. 4370), rabbit polyclonal anti-p44/42 MAPK (ERK1/2) (cat. no. 9102), rabbit monoclonal antiphospho-p38 MAPK (Thr180/Tyr182, 3D7, cat. no. 9215), mouse monoclonal anti-p38 MAPK (L53F8, cat. no. 9228), rabbit monoclonal anti-phospho-AKT (Ser473, 193H12, cat. no. 4058), rabbit polyclonal anti-AKT (cat. no. 9272), rabbit polyclonal anti-MEK1/2 (cat. no. 9122) and rabbit polyclonal anti-cleaved caspase-3 (Asp175, cat. no 9661) antibodies were from Cell Signalling Technology (dilution 1:1,000). Rabbit polyclonal anti-phospho-WAVE2 (Ser343, cat. no. 07-1512), rabbit polyclonal anti-phospho-WAVE2 (Ser351, cat. no. 07-1514) and mouse monoclonal anti-laminin-V (P3H9-2, cat. no. MAB1947) antibodies were from Merck/Millipore (dilution 1:500). Mouse monoclonal anti-WAVE2 and mouse monoclonal anti-ABI1 antibodies were homemade 54 (dilution 1:100). Rabbit polyclonal anti-NAP1 antibody was a gift from T. Stradal (Helmholtz Centre for Infection Research, Braunschweig, Germany) 55 . Rabbit polyclonal anti EGFR (806), directed against aa 1172-1186 of human EGFR (ImmunoBlot) and mouse monoclonal anti-EGFR (m108 hybridoma) directed against the extracellular domain of human EGFR (immunofluorescence) were a gift from P. P. Di Fiore (dilution 1:1,000). Secondary antibodies conjugated to horseradish peroxidase were all used at a dilution of 1:2,000 and were from: Bio-Rad (cat. nos. 7074 and 7076); Cy3-secondary antibodies from Jackson ImmunoResearch (cat. nos. 711-165-152 and 715-165-150); DAPI (cat. no. D-1306) and AlexaFluor 488 (A-11055 and A-21202) were from Thermo Fisher Scientific. TRITC (cat. no. P1951)-and FITC (cat. no. P5282)-conjugated phalloidin were from Sigma Aldrich.
Doxycycline hyclate (cat. no. D9891), dynasore hydrate (cat. no. D7693), AG1478 (cat. no. T4182), 5-(N-ethyl-N-isopropyl)amiloride (cat. no. 1154-25-2) and CK666 (cat. no. SML0006) were from Sigma Aldrich. PD0325901 (cat. no. 444966) was from Merck/Millipore. SCH772984 (cat. no. 942183-80-4) was from Selleckchem. FluoSpheres Sulfate Microspheres, 0.2 µm, yellow-green fluorescent (505/515), 2% solids (cat. no. F8848) were from ThermoFisher. Mitomycin C (cat. no. M0503) was from Sigma Aldrich.
Cell cultures and transfection. MCF10A cells were a gift from J. S. Brugge (Department of Cell Biology, Harvard Medical School, Boston, USA) and were maintained in Dulbecco's modified Eagle's medium:Nutrient Mixture F-12 (DMEM/F12) medium (Biowest) supplemented with 5% horse serum, 1% lglutamine (EuroClone), 0.5 mg ml −1 hydrocortisone (Sigma-Aldrich), 100 ng ml −1 cholera toxin (Sigma-Aldrich), 10 μg ml −1 insulin (Sigma-Aldrich) and 20 ng ml −1 EGF (Vinci Biochem). MCF10.DCIS.com cells were provided by J. F. Marshall (Barts Cancer Institute, Queen Mary University of London, UK) and maintained in DMEM/F12 medium supplemented with 5% horse serum, 1% l-glutamine, 0.5 mg ml −1 hydrocortisone, 10 μg ml −1 insulin and 20 ng ml −1 EGF. All cell lines have been authenticated by cell fingerprinting and tested for mycoplasma contamination. Cells were grown at 37 °C in an humidified atmosphere with 5% CO 2 . Phoenix-AMPHO cells (American Type Culture Collection, CRL-3213) were used as the packaging cell line for the generation of retroviral particles and cultured as recommended by the supplier. HEK293T cells were obtained from the BBCF-Biological Bank and Cell factory, INT, Milan and grown in DMEM supplemented with 10% fetal bovine serum and 2 mM l-glutamine and used as the packaging line for lentiviral vectors. MCF10A cells were infected with pSLIK-neo-EV (empty vector, CTR), pSLIK-neo-RAB5A, pSLIK-hygro-RAB5B or pSLIK-neo-RAB5C lentiviruses and selected with the appropriate antibiotic to obtain stable inducible cell lines. MCF10.DCIS.com were infected with pSLIK-neo-EV (empty vector, CTR) or pSLIK-neo-RAB5A lentiviruses and selected with the appropriate antibiotic to obtain stable inducible cell lines. Constitutive expression of EGFP-LifeAct, mCherry or EGFP-H2B was achieved by lentiviral and retroviral infection of MCF10A and MCF10DCIS.com cells with EGFP-LifeAct-puro or pBABE-puro-mCherry-H2B/pBABE-puro-EGFP-H2B vectors, respectively.
Transfections were performed using either calcium phosphate or FuGENE HD Transfection Reagent (cat. no. E2311, Promega), according to the manufacturer's instructions. FuGENE HD Transfection Reagent was used for FRET-EKAREV-ERK1/2 transfection in MCF10A cells.
Generation of lentiviral and retroviral particles.
Packaging of lentiviruses or retroviruses was performed following standard protocols. Viral supernatants were collected and filtered through 0.45 μm filters. Cells were subjected to four cycles of infection and selected using the appropriate antibiotic: neomycin for the pSLIK-neo vector (150 μg ml -1 ), hygromycin for the pSLIK-hygro vector (100 μg ml -1 ) or puromycin for the EGFP-LifeAct or pBABE vectors (2 μg ml -1 ). After several passages, stable bulk populations were selected and induced by doxycycline hyclate (2.5 μg ml -1 ) in order to test: (1) induction efficiency by western blotting and quantitative reverse-transcription polymerase chain reaction (qRT-PCR), and (2) the homogeneity of the cell pool by immunofluorescence staining, as previously shown 14 .
RNA interference. siRNA delivery was achieved by mixing 1 nM of specific siRNAs with Optimem and Lipofectamine RNAiMAX Transfection Reagent (Life Technologies). The first cycle of interference (reverse transfection) was performed on cells in suspension. The day after, a second cycle of interference (forward transfection) was performed on cells in adhesion. The following siRNAs were used for knocking down specific genes. All sequences are 5′ to 3′.
Dynamin2 ( For each RNA interference experiment, a negative control was performed with the same amount of scrambled siRNAs. Silencing efficiency was controlled by qRT-PCR.
Quantitative RT-PCR analysis. Quantitative RT-PCR analysis was performed as previously described 14 . Total RNA was extracted using the RNeasy Mini kit (Qiagen) and quantified by NanoDrop to assess both concentration and quality of the samples. Reverse transcription was performed using the SuperScript VILO cDNA Synthesis kit from Invitrogen. Gene expression was analysed by using the TaqMan Gene expression Assay (Applied Biosystems). 0.1 ng of cDNA was amplified, in triplicate, in a reaction volume of 25 μl with 10 pmol of each genespecific primer and the SYBR Green PCR MasterMix (Applied Biosystems). Real-time PCR was performed on the 14 ABI/Prism 7700 Sequence Detector System (PerkinElmer/Applied Biosystems) using a pre-PCR step of 10 min at 95 °C, followed by 40 cycles of 15 s at 95 °C and 60 s at 60 °C. Specificity of the amplified products was confirmed by melting curve analysis (Dissociation Curve TM; Perkin Elmer/Applied Biosystems) and by 6% PAGE. Preparations with RNA template without reverse transcription were used as negative controls. Samples were amplified with primers for each gene (for details see the quantitative PCR primer list below) and GAPDH as a housekeeping gene. The cycle threshold C t values were normalized to the GAPDH curve. PCR experiments were performed in triplicate and standard deviations calculated and displayed as error bars. Primer assay IDs were: GAPDH, Hs99999905_m1; RAB5A, Hs00702360_s1; RAB5B, Hs00161184_m1; RAB5C, Hs00428044_m1; dynamin2 (DNM2), Hs00974698_m1; clathrin heavy chain (CLTC), Hs00964480_m1; NAP1, Hs00980236_m1; WAVE2, Hs00819075_gh; reticulon3 (RTN3), Hs01581965_m1; reticulon4 (RTN4), Hs01103689_m1.
Immunoblotting. For protein extraction, cells, previously washed with cold phosphate-buffered saline (PBS), were lysed in JS buffer supplemented with proteases and phosphatases inhibitors (50 mM HEPES pH 7.5, 50 mM NaCl, 1% glycerol; 1% Triton X-100, 1.5 mM MgCl 2 ; 5 mM EGTA plus protease inhibitor cocktail (Roche Basel, Switzerland), 1 mM DTT, 20 mM Na pyrophosphate pH 7.5, 50 mM NaF, 0.5 M Na vanadate in HEPES pH 7.5 to inhibit phosphatases). Lysates were incubated on ice for 10 min and cleared by centrifugation at 13,000 r.p.m. for 30 min at 4 °C. Protein concentration was quantified by the Bradford colorimetric protein assay. The same amount of protein lysates was loaded onto polyacrylamide 63×/1.47 numerical aperture (NA) objective and equipped with Andor iXon DU-8285_VP was used to take pictures every 90 s. For protrusion velocity analysis, the morphodynamic quantification was performed using the ImageJ plugin ADAP (automated detection and analysis of protrusion) 56 .
Each assay was done five times and at least 25 cells per condition were counted in each experiment. Where indicated, PD0325901 or SCH772984 was added 1 h before imaging.
FRET analysis. Using a customized macro in ImageJ, FRET data were analysed using the ratiometric approach. Cyan fluorescent protein (CFP), yellow fluorescent protein (YFP) and FRET images were background subtracted, converted in 32 bits and the smoothed YFP images were tresholded and used as a mask to highlight the vesicular-like structures of interest. On these areas the average FRET/CFP ratio was then calculated as described in ref. 57 .
3D morphogenesis assay. The MCF10A morphogenesis assay was performed as previously described 58 . Briefly, MCF10A cells were trypsinized and resuspended in MCF10A culture medium. Eight-well chamber slides (cat. no. 80826 IBIDI) were coated with 40 μl per well of Growth Factor Reduced Matrigel Matrix Basement Membrane 10.2 mg ml -1 (cat. no. 354263, Corning) or with a 1:1 mixture of Matrigel HC 10.2 mg ml -1 and type I bovine collagen 3 mg ml -1 (cat. no. 5005 Advanced BioMatrix). Once the matrix was polymerized, 2.5 × 10 3 cells were plated into each well on top of the matrix layer in culture medium supplemented with 2% Matrigel HC 10.2 mg ml -1 and 5 ng ml -1 EGF. Complete acini morphogenesis was allowed by incubating the cells for three weeks and replacing assay media every four days.
On day 21 acini were treated with 2.5 μg ml -1 doxycycline hyclate to induce RAB5A expression. Cells were maintained under stimulation for six days, changing the medium every two days, before fixation with 4% paraformaldehyde and staining with specific antibodies. When inhibitors were used, the media were refreshed every day.
3D spheroid kinematic assay. MCF10DCIS.com cells were plated on ultralow-attachment-surface six-well plates (cat. no. 3471 Corning) at a density of 5 × 10 3 cells per well. Cells were grown in serum-free conditions for 10 days by adding fresh culture media every 2 days. Then spheres from every single well were collected and resuspended in 150 μl of 6 mg ml -1 collagen type I (cat. no 35429 Corning), and diluted in culture media, 50 mM Hepes, 0.12 NaHCO 3 and 5 mM NaOH. The unpolymerized mix of spheres/collagen was placed in eightwell chamber slides and incubated at 37 °C overnight. The following day, before imaging, 2.5 μg ml -1 doxycycline hyclate was added to the polymerized collagen mix to induce RAB5A expression. For the collagen mechanical stress analysis, 20 μl of FluoSpheres Sulfate Microspheres, 0.2 µm (cat. no. F8848 ThermoFisher) were added to the unpolymerized mix of spheres/collagen and the protocol was carried out following the same conditions as previously described.
Ex vivo DCIS tumour slice motility assay.
All animal experiments were approved by the OPBA (Organisms for the well-being of the animal) of IFOM and Cogentech. All experiments complied with national guidelines and legislation for animal experimentation. All mice were bred and maintained under specific pathogen-free conditions in our animal facilities at Cogentech Consortium at the FIRC Institute of Molecular Oncology Foundation and at the European Institute of Oncology in Milan, under the authorization from the Italian Ministry of Health (Autorizzazione N° 604-2016).
For mammary fat pad tumour development in NSG mice MCF10DCIS. com cells were trypsin detached, washed twice and resuspended in PBS to a final concentration 2 × 10 5 per 13 μl. The cell suspension was then mixed with 5 μl growth factor-reduced Matrigel and 2 μl Trypan blue solution and maintained on ice until injection. Aseptic conditions under a laminar flow hood were used throughout the surgical procedure. Female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (commonly known as the NOD SCID gamma; NSG) mice, 6-9 weeks old, were anaesthetized with 375 mg kg -1 Avertin, laid on their backs and injected with a 20 μl cell suspension directly in the fourth mammary fad pad. After four weeks, mice were killed and the primary tumours were removed, cut by a scalpel and each tumour slide was placed over a metal grid inserted in a six-well plate to allow tumours to grow on an interface air/culture medium. Before imaging, 2.5 μg ml -1 doxycycline hyclate was added to the tumour slices culture media to induce RAB5A expression. Tumour cells were maintained under stimulation for three days, changing the medium every day.
Immunofluorescence. As previously described 14 , cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 and 1% BSA for 10 min (except for EEA-1 staining, permeabilized with 0.02% Saponin and 1% BSA for 10 min, and pERK1/2 staining, permeabilized with ice cold 100% methanol for 10 min). In EGFR staining experiments, the permeabilization step was avoided where indicated (non-permeabilized conditions) in order to detect only total cell surface EGFR. After a 1X PBS wash, primary antibodies were added for 1 h at room temperature. Coverslips were washed in 1X PBS before secondary antibody incubation for 1 h at room temperature, protected from light. FITC-or TRITC-gel in 5X SDS sample buffer. Proteins were transferred onto Protran Nitrocellulose Transfer membranes (Whatman), probed with the appropriate antibodies and visualized with ECL western blotting detection reagents (GE Healthcare). Membrane blocking and incubation in primary or secondary antibodies were performed for 1 h in TBS/0.1% Tween/5% milk for antibodies recognizing the total proteins or in TBS/0.1% Tween/5% bovine serum albumin (BSA) for antibodies recognizing phosphorylated proteins.
Uncropped gels of the main immunoblots are presented in Supplementary  Figs. 11 and 12. Immunohistochemistry on DCIS and IDC. Sections from archival human breast cancer samples were collected from the archives of the Tumor Immunology Laboratory of the Human Pathology Section, Department of Health Sciences, University of Palermo, Italy.
Immunohistochemistry was performed using a polymer detection method (Novolink Polymer Detection Systems Novocastra, Leica Biosystems, Newcastle, product no. RE7280-K).
Tissue samples were fixed in 10% buffered formalin and embedded in paraffin. Four-micrometre-thick tissue sections were dewaxed and rehydrated. The antigen unmasking technique was performed using Novocastra Epitope Retrieval Solution pH 6 citrate-based buffer in a thermostatic water bath at 98 °C for 30 min. Subsequently, the sections were brought to room temperature and washed in PBS-Tween. After neutralization of the endogenous peroxidases with 3% H 2 O 2 and protein blocking by a specific protein block, the samples were incubated for 1 h with monoclonal rabbit anti-human RAB5A (EPR5438) (ab109534) (dilution 1:100, Abcam). Staining was revealed by a polymer detection kit (Novocastra, Ltd) and 3-amino-9-ethylcarbazole (AEC) substrate chromogen. The slides were counterstained with Harris haematoxylin (Novocastra, Ltd). All the sections were analysed under a Zeiss Axio Scope A1 optical microscope (Zeiss, Germany) and microphotographs were collected using an Axiocam 503 Color digital camera with the ZEN2 imaging software (blue edition) (Zeiss Germany).
For quantitative analysis of RAB5A IHC, non-overlapping areas, each corresponding to a ×400 high-power microscopic field, were selected from digital slide scans obtained using an Aperio CS2 slide scanner (Leica Microsystems). A total of 80 fields corresponding to DCIS fields, fields with in situ and associated infiltrating foci, and overtly infiltrative IDC fields were analysed. The percentage of strong positive cells (+3 score) per field was determined using the Aperio ImageScope software and the Positive Pixel Count v9 Algorithm (Leica Microsystems).
In situ mRNA hybridization on DCIS and IDC. In situ mRNA hybridization for the RAB5A transcript was performed on 4-μm-thick formalin-fixed paraffinembedded sections of DCIS and IDC. The RNAscope 2.0 HD Reagent Kit (Advanced Cell Diagnostics, Hayward, CA, USA) was adopted according to the manufacturer's instructions, using an ad-hoc-designed RAB5A-specific probe (C1 Custom Probe-Hs-RAB5A (targeting 424-2098 of NM_001292048.1)).
All the slides were analysed under a Zeiss Axio Scope A1 optical microscope (Zeiss, Germany) and microphotographs were collected using an Axiocam 503 Color digital camera with the ZEN2 imaging software (Zeiss Germany).
Cell streaming and wound healing assays. As previously shown 14 , cells were seeded in six-well plates (1.5 × 10 6 cells per well) in complete medium and cultured until a uniform monolayer had formed. RAB5A expression was induced, where indicated, 16 h before performing the experiment by adding fresh complete media supplemented with 2.5 μg ml -1 doxycycline hyclate to cells. Comparable cell confluence was tested by taking pictures by differential interference contrast imaging using a 10× objective and counting the number of nuclei per field. In the cell streaming assay, the medium was refreshed before imaging began. In the wound healing assay, the cell monolayer was scratched with a pipette tip and carefully washed with 1X PBS to remove floating cells and to create a cell-free wound area. The closure of the wound was monitored by time-lapse microscopy. An Olympus ScanR inverted microscope with 10× objective was used to take pictures every 5-10 min over a 24 h period (as indicated in the captions of Figs. 1a,b and 5a). The assay was performed using an environmental microscope incubator set to 37 °C and 5% CO 2 perfusion. After cell induction, doxycycline hyclate was maintained in the media for the total duration of the time-lapse experiment. The percentage of area covered by cells (area coverage %) over time and wound-front speed were calculated by MatLab software. In the chemical inhibitors' experiments, the inhibitor was added together with doxycycline hyclate in fresh media 1 h before starting imaging. For the cell streaming assay performed on interfered cells, cells were interfered in suspension (first cycle) and directly plated at the desired concentration, following the same conditions already described in the 'RNA interference' section.
For detection of cryptic lamellipodia, MCF10A cells stably expressing EGFP-LifeAct were mixed in a 1:10 ratio with unlabelled cells and seeded in the cell streaming assay, as described before. Cell migration was monitored by time-lapse phase contrast and fluorescence microscopy, collecting images at multiple stage positions in each time loop. An Olympus ScanR inverted microscope with a 20× objective (+1.6× Optovar) or with a Leica AM TIRF MC mic with HCX PL APO EKAREV FRET analysis was performed using a DeltaVision Elite imaging system (Applied Precision) controlled by softWoRx Explorer 2.0 (Applied Precision) equipped with a DV Elite CMOS camera and an inverted microscope (IX71; Olympus) using a PlanApo N 60×/1.42 NA oil-immersion objective lens.
The ex vivo DCIS tumour slice motility assay was performed using an Olympus IX83 inverted microscope controlled by The Olympus cellSens Standard software (Olympus, https://www.olympus-lifescience.com/en/software/cellsens/) and equipped with an iXon Ultra Andor (EMCCD) 16 bit camera using an UplanSApo 10×/0.4 NA dry objective.
Atomic force microscopy (AFM) measurements of collagen gels. Collagen gel samples at different concentrations (2, 4, 6 mg ml -1 ) were prepared as previously described in wells obtained by binding a microfabricated polydimethylsiloxane ring (height = 2 mm, outer diameter = 10 mm, inner diameter = 6 mm) to 24-mmround glass coverslips via plasma treatment of the surfaces.
The stiffness of collagen gel samples was measured at 37 °C by using NanoWizard3 AFM (JPK, Germany) coupled to an Olympus inverted microscope. A silicon nitride AFM probe (nominal spring constant of 0.03 N m -1 : NovaScan, USA) functionalized with a borosilicate microsphere (10 µm in diameter) was used for AFM indentation. Before the measurements, the deflection sensitivity and spring constant of the cantilever were calibrated in PBS on glass at 37 °C.
Collagen gel stiffness was measured by bringing the bead-functionalized cantilever tip into contact with the matrix surface at 30 (or more) different positions. For each position five force curves were recorded. The contact force was set at a threshold value of 2 nN, the approach-retraction distance was 10 μm, and the approach velocity was 10 μm s -1 .
The data points below 0.8 μm indentation depth were used to calculate the elastic (Young) modulus, by fitting the curves with the Hertz model:
